Jaume Notario

4PUBLICATIONS
15CO-AUTHORS
PainNanotoxicology, health and safetyGeriatrics and gerontologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 21, 2025
Demographic and Clinical Characteristics, Patterns of Treatment, Quality of Life, and Resource Consumption Associated with the Management of Patients with Moderate to Severe Psoriasis in Clinical Practice in Spain: The SUMMER Project.

Jaime Notario, Jorge Magdaleno-Tapial, Raquel Rivera

|Sep 05, 2025
Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country.

Sandra Pérez-Recio, Maria D Grijota-Camino, Jordi Guardiola

|May 20, 2022
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group.

Elena Del Alcázar, Anna López-Ferrer, Álvaro Martínez-Doménech

|Nov 08, 2019
Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study.

M Colls-Gonzalez, J Notario-Rosa, J Bas-Minguet

Pageof 1

Frequent Collaborators

1 joint publications

M Colls-Gonzalez

1 joint publications

J Bas-Minguet

1 joint publications

A Padullés-Zamora

1 joint publications

F Morandeira-Rego